Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Renovaro Inc. - Common Stock (NQ: RENB ) 0.5230 -0.0756 (-12.63%) Streaming Delayed Price Updated: 4:00 PM EDT, Sep 3, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Press Releases about Renovaro Inc. - Common Stock < Previous 1 2 3 Next > Renovaro, Inc. Announces $10 million in Equity Committed June 14, 2024 From Renovaro Inc Via GlobeNewswire Impressive Short Squeeze Triggered for Cancer Immunotherapy Company Renovaro, Inc. (NASDAQ: RENB) June 10, 2024 Via Get News Topics Artificial Intelligence Exposures Artificial Intelligence Renovaro Inc. and Amsterdam UMC Cancer Center Poised to Advance Cancer Immunotherapy May 24, 2024 From Renovaro Inc Via GlobeNewswire Biotechs Zero in on New Pancreatic Therapies as Global Pancreatic Cancer Market Expected Reach to $7.4 Billion By 2032 May 24, 2024 EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NASDAQ:RENB),(NASDAQ:CYTO),(NYSE:PFE),(NYSE:ABBV) EQNX::TICKER_END Via FinancialNewsMedia Topics Death Exposures Death Biotechs Zero in on New Pancreatic Therapies as Global Pancreatic Cancer Market Expected Reach to $7.4 Billion By 2032 May 24, 2024 From FN Media Group LLC Via GlobeNewswire Launch of Groundbreaking Cancer Detection Platform Flamingo with Nvidia AI Computing Power, Plus Plans to Acquire 100% Ownership of Cyclomics: Renovaro Inc. (Nasdaq: RENB) April 30, 2024 Via Get News Topics Artificial Intelligence Exposures Artificial Intelligence Transforming Cancer Detection: RenovaroCube Introduces Flamingo, a novel AI model based on Fragmentomics April 30, 2024 From Renovaro Inc Via GlobeNewswire Trailblazing AI Driven Early Cancer Diagnostics and Therapeutics for Detection with Nvidia Super Computing Power; Acquiring 100% Ownership of Cyclomics; Renovaro Inc. (Nasdaq: RENB) April 25, 2024 Via Get News Topics Artificial Intelligence Exposures Artificial Intelligence RenovaroCube to Acquire 100% Ownership of Cyclomics, Reinforcing Cutting-Edge Cancer Diagnostics Partnership April 24, 2024 From Renovaro Inc Via GlobeNewswire Renovaro Inc. Proudly Announces the Appointment Of Professor Dr. Geert Kazemier as the Chairman of its Scientific Advisory Board, A Move That Heralds a New Era of Innovation and Progress in its Mission to Reshape Cancer Screening, Diagnosis, and Patient April 18, 2024 From Renovaro Biosciences Inc. Via GlobeNewswire Bragar Eagel & Squire, P.C. Is Investigating Waldencast, Chemours, Trupanion, and Renovaro and Encourages Investors to Contact the Firm March 04, 2024 From Bragar Eagel & Squire Via GlobeNewswire ROSEN, NATIONAL TRIAL COUNSEL, Encourages Renovaro Biosciences Inc. Investors to Inquire About Securities Class Action Investigation - RENB February 27, 2024 Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. Via NewMediaWire ROSEN, NATIONAL TRIAL COUNSEL, Encourages Renovaro Biosciences Inc. Investors to Inquire About Securities Class Action Investigation - RENB February 27, 2024 WHY: NEW YORK, NY - (NewMediaWire) - February 27, 2024 - Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Renovaro... Via TheNewswire.com ROSEN, A TOP RANKED LAW FIRM, Encourages Renovaro Biosciences Inc. Investors to Inquire About Securities Class Action Investigation – RENB February 24, 2024 From The Rosen Law Firm PA Via GlobeNewswire RENOVARO ALERT: Bragar Eagel & Squire, P.C. is Investigating Renovaro Biosciences Inc. on Behalf of Renovaro Stockholders and Encourages Investors to Contact the Firm February 20, 2024 From Bragar Eagel & Squire Via GlobeNewswire ROSEN, A LEADING LAW FIRM, Encourages Renovaro Biosciences Inc. Investors to Inquire About Securities Class Action Investigation - RENB February 20, 2024 Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. Via NewMediaWire ROSEN, A LEADING LAW FIRM, Encourages Renovaro Biosciences Inc. Investors to Inquire About Securities Class Action Investigation - RENB February 20, 2024 WHY: NEW YORK, NY - (NewMediaWire) - February 20, 2024 - Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Renovaro... Via TheNewswire.com RENB SHAREHOLDER ALERT: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Renovaro Biosciences Inc. Investors to Inquire About Securities Class Action Investigation – RENB February 19, 2024 From The Rosen Law Firm PA Via GlobeNewswire Cutting Edge Blood Genetic Testing Using Nvidia AI Chips Emerging from Acquisition of Dutch Based Cyclomics; Aim to Disrupt Cancer Diagnosis and Treatment: Renovaro Biosciences Inc. (Nasdaq: RENB) February 16, 2024 Via Get News Topics Artificial Intelligence Exposures Artificial Intelligence Cutting Edge AI Company GEDiCube and Cyclomics sign binding LOI to join forces and position themselves at the forefront of the global liquid biopsy marketplace February 15, 2024 From Renovaro Biosciences Inc. Via GlobeNewswire Statement of Renovaro Inc February 14, 2024 From Renovaro Biosciences Inc. Via GlobeNewswire BioMedNewsBreaks – Renovaro Inc. (NASDAQ: RENB) Fusing AI and Biotech to Accelerate Personalized Medicine, GEDiCube, Cyclomics Enter LOI to ‘Change the Field’ February 13, 2024 Via Investor Brand Network Topics Artificial Intelligence Exposures Artificial Intelligence ROSEN, A LEADING NATIONAL FIRM, Encourages Renovaro Biosciences Inc. Investors to Inquire About Securities Class Action Investigation – RENB February 13, 2024 From The Rosen Law Firm, P.A. Via Business Wire Cutting Edge AI Company GEDiCube and Cyclomics sign binding LOI to join forces and position themselves at the forefront of the global liquid biopsy marketplace February 13, 2024 From Renovaro Biosciences Inc. Via GlobeNewswire AI Pioneer GEDi Cube and Biotech Innovator Renovaro Biosciences Combine Forces to Accelerate Personalized Medicine February 13, 2024 From Renovaro Biosciences Inc. Via GlobeNewswire Patients with Swelling Disorder See New Gene Therapy as Godsend February 07, 2024 Via Investor Brand Network Study Explains Why Immunotherapy Could Trigger Colitis in Cancer Patients January 25, 2024 Via Investor Brand Network BioMedNewsBreaks – Renovaro BioSciences Inc. (NASDAQ: RENB) Announces Results of Special Meeting January 25, 2024 Via Investor Brand Network Renovaro Biosciences Announces Results of Special Meeting of Shareholders January 25, 2024 From Renovaro Biosciences Inc. Via GlobeNewswire BioMedNewsBreaks — Renovaro BioSciences Inc. (NASDAQ: RENB) Releases CEO Shareholder Message January 16, 2024 Via Investor Brand Network Topics Artificial Intelligence Exposures Artificial Intelligence < Previous 1 2 3 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.